Primopus looks forward to the year ahead
January 4th, 2024

Progress is being made in the multiple interest areas of our phosphoramidites brand, Amideus. We are fairly unique in having a dedicated team working on phosphoramidites for volume application for CDMO purposes. An increasing area of focus is Fmoc Amino Acids where important news will soon be released.
We are meeting the various challenges in all our work with resolute thinking aligned to rigorous SOP. We look forward to working with a growing number of partners across multiple projects in the year ahead.